Alteration of Wnt5a expression and of the non-canonical Wnt/PCP and Wnt/PKC-Ca²⁺ pathways in human osteoarthritis osteoblasts by Xavier Martineau (4332922)

“…</p><p>Conclusion</p><p>These data indicate that the alteration of Wnt5a, a non-canonical Wnt signaling activator, is implicated in the modified signalisation and phenotype observed in OA Ob.…”

Circular dichroism (CD) spectrometry analyses of hGRNL, bNK2A, and pNKL peptides. by Erika N. Biernbaum (12647386)

Treatment with the antioxidant <i>N</i>-Acetyl-L-Cysteine (NAC) or with the p53 inhibitor, Pifithrin-α (PFT), prevents ROS formation in hMp84-overexpressing A375 cells. by Daniele Moretti (379766)

Heparanase activity in murine (A) and human (B) sepsis. by Lukas Martin (747245)

Heparanase level in murine (A) and human (B) sepsis. by Lukas Martin (747245)

Neural variability and correlations decrease during task states relative to rest in spiking data. by Takuya Ito (57473)

Treatment with the antioxidant <i>N</i>-Acetyl-L-Cysteine (NAC) or with the p53 inhibitor, Pifithrin-α (PFT), prevents cell death in hMp84-overexpressing A375 cells. by Daniele Moretti (379766)

Binding mode of clavulanic acid with active site residues of SHV S130G mutant at different time intervals (a) binding of ca at 0 ns (b) binding of ca at 2 ns (c) binding of ca at 5... by Mohd Hassan Baig (441304)

Conditional <i>Aff4</i> knockout decreases fat mass in mice. by Yaqian Chen (1711576)

Expression of vTR harboring the mutant template (AU5) decreases cell proliferation of an avian cancer cell line. by Benedikt B. Kaufer (341018)

RhoE gt/gt mice show a delay in neuromuscular junction maturation and a decrease in the number of spinal motoneurons. by Enric Mocholí (223047)

JBPOS0101 decreased Amyloid Beta (Aβ) aggregates in the cortex and hippocampal regions in 5xFAD mouse brains. by Jihoon Jeong (4852690)

C1INH significantly decreased renal C5a cleavage and limited C3b deposition in kidneys subjected to IRI. by Juan S. Danobeitia (4386205)

Participants characteristics. by Sakiko Fukui (387048)

Subjects:

(a–f) Pooled sensitivity and specificity by IFU conformity, Ct-value*, sample type, symptom status, duration of symptoms, and age. by Lukas E. Brümmer (11269299)

Subjects:

Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

“…RBP-4 was increased in the sitagliptin non-ischemic group (SIT-N) compared to CON-N. There was a significant decrease in RBP-4 in the sitagliptin ischemic (SIT-I) myocardium compared to CON-I to levels similar to the CON-N myocardium. …”

Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

Experimental procedure. by Nakako Okamoto (18501452)

At E9.5 Actb^−/− neural crest cells show a significant decrease of cadherin-11 expression. by Davina Tondeleir (426905)

“…<p>(A) Quantification of N-cadherin intensities in Actb^+/+ and Actb^−/− migratory cells adjacent to the neural tube at E8.5 and E9.5 (left graph, Y-axis: relative intensities) and colocalization of N-cadherin with p75 in migratory cells at E8.5 and E9.5 (right graph, Y-axis: colocalization index on a scale from 0 to 1). …”

DCB-3503 did not decrease mRNA levels of cyclin D1, survivin, β-catenin, p53, and p21. by Ying Wang (11406)